David M Rancour

Title: David M Rancour: Innovator in Biopharmaceuticals

Introduction

David M Rancour is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of recombinant polypeptides. With a total of 2 patents to his name, Rancour's work focuses on innovative solutions to combat viral infections.

Latest Patents

Rancour's latest patents include groundbreaking research on recombinant polypeptides containing immunogenic fragments of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein. The first patent details a recombinant polypeptide that includes at least one immunogenic fragment and its pharmaceutical compositions. The second patent expands on this concept by incorporating an antibody Fc region, further enhancing the potential therapeutic applications of these polypeptides.

Career Highlights

David M Rancour is currently employed at Boost Biopharma, Inc., where he continues to push the boundaries of biopharmaceutical research. His work is instrumental in developing new treatments that could significantly impact public health.

Collaborations

Rancour collaborates with various professionals in the field, including his coworker Fritz Michael Schomburg. Their combined expertise contributes to the advancement of innovative biopharmaceutical solutions.

Conclusion

David M Rancour's contributions to the field of biopharmaceuticals through his patents and work at Boost Biopharma, Inc. highlight his role as a key innovator in combating viral diseases. His research continues to pave the way for future advancements in medical science.